Observational long-term follow-up study of rapid food oral immunotherapy with omalizumab

A number of clinical studies focused on treating a single food allergy through oral immunotherapy (OIT) with adjunctive omalizumab treatment have been published. We previously demonstrated safety and tolerabil...

Source: Allergy, Asthma and Clinical Immunology - December 21, 2017 Category: Allergy & Immunology Authors: Sandra Andorf, Monali Manohar, Tina Dominguez, Whitney Block, Dana Tupa, Rohun A. Kshirsagar, Vanitha Sampath, R. Sharon Chinthrajah and Kari C. Nadeau Tags: Research Source Type: research